Table 1.
Study population | CR + PR | SD + PD | P value |
---|---|---|---|
N = 63 | N = 56 | N = 7 | |
Age (years) | |||
Median | 65 | 63 | 0.23 |
Range | 43–82 | 55–67 | |
Sex | |||
Female | 19 | 1 | 0.42 |
Male | 37 | 6 | |
Stage | |||
I-II | 6 | 1 | 0.43 |
III | 48 | 5 | |
IV | 2 | 1 | |
Tumor length | |||
<5 cm | 15 | 3 | 0.34 |
≥5 cm | 4 | 4 | |
Acute hematologic toxicity | |||
0/I-II | 53 | 6 | 0.38 |
III-IV | 3 | 1 | |
Acute organ toxicity | |||
0/I-II | 48 | 5 | 0.31 |
III-IV | 8 | 2 |
CR + PR: patients with complete or partial response; SD + PD: patients with stable disease or progressive disease.